サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1412414

糖脂質市場：製品タイプ別、用途別-2024-2030年の世界予測

Glycolipids Market by Product (Glycosphongolipid, Glycosyl Triacylglycerol), Type (Mammalian Glycolipids, Microbial Glycolipids), Application - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 197 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
糖脂質市場：製品タイプ別、用途別-2024-2030年の世界予測
出版日: 2024年01月15日
発行: 360iResearch
ページ情報: 英文 197 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

糖脂質市場規模は2023年に22億6,000万米ドルと推計され、2024年には24億2,000万米ドルに達し、CAGR 6.92%で2030年には36億1,000万米ドルに達すると予測されます。

糖脂質の世界市場

主な市場の統計
基準年[2023］ 22億6,000万米ドル
予測年[2024］ 24億2,000万米ドル
予測年 [2030] 36億1,000万米ドル
CAGR（%） 6.92%
糖脂質 Market-IMG1

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは糖脂質市場を評価する上で極めて重要です。事業戦略と製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、糖脂質市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-糖脂質市場の市場規模および予測は？

2-糖脂質市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-糖脂質市場における技術動向と規制の枠組みは？

4-糖脂質市場における主要ベンダーの市場シェアは？

5-糖脂質市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 再生可能な天然原料の使用に対する消費者の意識の高まり
      • 土壌条件を改善するための緑色界面活性剤の需要の増加
      • 自然の淡水および海洋環境における無駄を排除するための糖脂質の使用の増加
    • 抑制要因
      • 原材料と精製プロセスに関連するコストが高い
    • 機会
      • 新しい糖脂質製造プロセスの実装のための研究開発活動に対する政府の資金援助
      • 生物医学および薬用化粧品用途での糖脂質の人気が高まりつつある
    • 課題
      • 水溶液に対する溶解性の欠如
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 糖脂質市場：製品別

  • スホン糖脂質
  • グリコシルトリアシルグリセロール

第7章 糖脂質市場：タイプ別

  • 哺乳類の糖脂質
  • 微生物糖脂質

第8章 糖脂質市場：用途別

  • 農業
  • 化粧品とパーソナルケア
  • 医薬品の開発と提供
  • 食品業界

第9章 南北アメリカの糖脂質市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域の糖脂質市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカの糖脂質市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析

第13章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • AkzoNobel N.V.
    • BASF SE
    • Biosynth Ltd.
    • Cargill Incorporated
    • CD Bioparticles
    • Croda International PLC
    • DuPont de Nemours, Inc.
    • Ecover
    • Evonik Industries AG
    • Givaudan SA
    • Henkel Corporation
    • Jeneil Biotech, Inc.
    • Koninklijke DSM N.V.
    • LANXESS Deutschland GmbH
    • Lasenor Emul S.A.
    • Lecico GmbH
    • Lipoid GmbH
    • Locus Performance Ingredients
    • Lyxia Corporation
    • Patanjali Foods Ltd.
    • Qualitas Health
    • Solvay S.A.
    • Stern-Wywiol Gruppe GmbH & Co. KG
    • The Archer-Daniels-Midland Company
    • The Lubrizol Corporation
    • Vav Life Sciences
  • 主要な製品ポートフォリオ

第14章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. GLYCOLIPIDS MARKET RESEARCH PROCESS
  • FIGURE 2. GLYCOLIPIDS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLYCOLIPIDS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLYCOLIPIDS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLYCOLIPIDS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLYCOLIPIDS MARKET DYNAMICS
  • FIGURE 7. GLYCOLIPIDS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. GLYCOLIPIDS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLYCOLIPIDS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 10. GLYCOLIPIDS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLYCOLIPIDS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. GLYCOLIPIDS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS GLYCOLIPIDS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS GLYCOLIPIDS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES GLYCOLIPIDS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES GLYCOLIPIDS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC GLYCOLIPIDS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC GLYCOLIPIDS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA GLYCOLIPIDS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA GLYCOLIPIDS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. GLYCOLIPIDS MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 22. GLYCOLIPIDS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. GLYCOLIPIDS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLYCOLIPIDS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL GLYCOLIPIDS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLYCOLIPIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 6. GLYCOLIPIDS MARKET SIZE, BY GLYCOSPHONGOLIPID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. GLYCOLIPIDS MARKET SIZE, BY GLYCOSYL TRIACYLGLYCEROL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. GLYCOLIPIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 9. GLYCOLIPIDS MARKET SIZE, BY MAMMALIAN GLYCOLIPIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLYCOLIPIDS MARKET SIZE, BY MICROBIAL GLYCOLIPIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLYCOLIPIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 12. GLYCOLIPIDS MARKET SIZE, BY AGRICULTURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLYCOLIPIDS MARKET SIZE, BY COSMETICS & PERSONAL CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLYCOLIPIDS MARKET SIZE, BY DRUG DEVELOPMENT & DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLYCOLIPIDS MARKET SIZE, BY FOOD INDUSTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS GLYCOLIPIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS GLYCOLIPIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS GLYCOLIPIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS GLYCOLIPIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA GLYCOLIPIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA GLYCOLIPIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA GLYCOLIPIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL GLYCOLIPIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL GLYCOLIPIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL GLYCOLIPIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. CANADA GLYCOLIPIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA GLYCOLIPIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA GLYCOLIPIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. MEXICO GLYCOLIPIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO GLYCOLIPIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO GLYCOLIPIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. UNITED STATES GLYCOLIPIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES GLYCOLIPIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES GLYCOLIPIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES GLYCOLIPIDS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 36. ASIA-PACIFIC GLYCOLIPIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC GLYCOLIPIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC GLYCOLIPIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC GLYCOLIPIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 40. AUSTRALIA GLYCOLIPIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA GLYCOLIPIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA GLYCOLIPIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. CHINA GLYCOLIPIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA GLYCOLIPIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA GLYCOLIPIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. INDIA GLYCOLIPIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA GLYCOLIPIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA GLYCOLIPIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. INDONESIA GLYCOLIPIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA GLYCOLIPIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA GLYCOLIPIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. JAPAN GLYCOLIPIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN GLYCOLIPIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN GLYCOLIPIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. MALAYSIA GLYCOLIPIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA GLYCOLIPIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA GLYCOLIPIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. PHILIPPINES GLYCOLIPIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES GLYCOLIPIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES GLYCOLIPIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. SINGAPORE GLYCOLIPIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE GLYCOLIPIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE GLYCOLIPIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. SOUTH KOREA GLYCOLIPIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA GLYCOLIPIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA GLYCOLIPIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. TAIWAN GLYCOLIPIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN GLYCOLIPIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN GLYCOLIPIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. THAILAND GLYCOLIPIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND GLYCOLIPIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND GLYCOLIPIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. VIETNAM GLYCOLIPIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM GLYCOLIPIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM GLYCOLIPIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA GLYCOLIPIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA GLYCOLIPIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA GLYCOLIPIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA GLYCOLIPIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 80. DENMARK GLYCOLIPIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK GLYCOLIPIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK GLYCOLIPIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. EGYPT GLYCOLIPIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT GLYCOLIPIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT GLYCOLIPIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. FINLAND GLYCOLIPIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND GLYCOLIPIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND GLYCOLIPIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. FRANCE GLYCOLIPIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE GLYCOLIPIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE GLYCOLIPIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. GERMANY GLYCOLIPIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY GLYCOLIPIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY GLYCOLIPIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. ISRAEL GLYCOLIPIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL GLYCOLIPIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL GLYCOLIPIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. ITALY GLYCOLIPIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY GLYCOLIPIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY GLYCOLIPIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. NETHERLANDS GLYCOLIPIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS GLYCOLIPIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS GLYCOLIPIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. NIGERIA GLYCOLIPIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA GLYCOLIPIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA GLYCOLIPIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. NORWAY GLYCOLIPIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY GLYCOLIPIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY GLYCOLIPIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. POLAND GLYCOLIPIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND GLYCOLIPIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND GLYCOLIPIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. QATAR GLYCOLIPIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR GLYCOLIPIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR GLYCOLIPIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. RUSSIA GLYCOLIPIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA GLYCOLIPIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA GLYCOLIPIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. SAUDI ARABIA GLYCOLIPIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA GLYCOLIPIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA GLYCOLIPIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. SOUTH AFRICA GLYCOLIPIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA GLYCOLIPIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA GLYCOLIPIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. SPAIN GLYCOLIPIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN GLYCOLIPIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN GLYCOLIPIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SWEDEN GLYCOLIPIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN GLYCOLIPIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN GLYCOLIPIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SWITZERLAND GLYCOLIPIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND GLYCOLIPIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND GLYCOLIPIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. TURKEY GLYCOLIPIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY GLYCOLIPIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY GLYCOLIPIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. UNITED ARAB EMIRATES GLYCOLIPIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES GLYCOLIPIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES GLYCOLIPIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED KINGDOM GLYCOLIPIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM GLYCOLIPIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM GLYCOLIPIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. GLYCOLIPIDS MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 144. GLYCOLIPIDS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 145. GLYCOLIPIDS MARKET LICENSE & PRICING
目次
Product Code: MRR-C002B1C99506

[197 Pages Report] The Glycolipids Market size was estimated at USD 2.26 billion in 2023 and expected to reach USD 2.42 billion in 2024, at a CAGR 6.92% to reach USD 3.61 billion by 2030.

Global Glycolipids Market

KEY MARKET STATISTICS
Base Year [2023] USD 2.26 billion
Estimated Year [2024] USD 2.42 billion
Forecast Year [2030] USD 3.61 billion
CAGR (%) 6.92%
Glycolipids Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Glycolipids Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Glycolipids Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Glycolipids Market, highlighting leading vendors and their innovative profiles. These include AkzoNobel N.V., BASF SE, Biosynth Ltd., Cargill Incorporated, CD Bioparticles, Croda International PLC, DuPont de Nemours, Inc., Ecover, Evonik Industries AG, Givaudan SA, Henkel Corporation, Jeneil Biotech, Inc., Koninklijke DSM N.V., LANXESS Deutschland GmbH, Lasenor Emul S.A., Lecico GmbH, Lipoid GmbH, Locus Performance Ingredients, Lyxia Corporation, Patanjali Foods Ltd., Qualitas Health, Solvay S.A., Stern-Wywiol Gruppe GmbH & Co. KG, The Archer-Daniels-Midland Company, The Lubrizol Corporation, and Vav Life Sciences.

Market Segmentation & Coverage

This research report categorizes the Glycolipids Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Glycosphongolipid
    • Glycosyl Triacylglycerol
  • Type
    • Mammalian Glycolipids
    • Microbial Glycolipids
  • Application
    • Agriculture
    • Cosmetics & Personal Care
    • Drug Development & Delivery
    • Food Industry
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Glycolipids Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Glycolipids Market?

3. What are the technology trends and regulatory frameworks in the Glycolipids Market?

4. What is the market share of the leading vendors in the Glycolipids Market?

5. Which modes and strategic moves are suitable for entering the Glycolipids Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Glycolipids Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising consumer awareness for the use of renewable and natural ingredients
      • 5.1.1.2. Increase in demand for green surfactants to boost soil conditions
      • 5.1.1.3. Growing usage of glycolipids for eliminating waste in natural freshwater and marine environment
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with raw materials and purification process
    • 5.1.3. Opportunities
      • 5.1.3.1. Government funding for R&D activities for implementation of novel glycolipids manufacturing process
      • 5.1.3.2. Emerging popularity of glycolipids for biomedical and cosmeceutical applications
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of solubility in aqueous solutions
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Glycolipids Market, by Product

  • 6.1. Introduction
  • 6.2. Glycosphongolipid
  • 6.3. Glycosyl Triacylglycerol

7. Glycolipids Market, by Type

  • 7.1. Introduction
  • 7.2. Mammalian Glycolipids
  • 7.3. Microbial Glycolipids

8. Glycolipids Market, by Application

  • 8.1. Introduction
  • 8.2. Agriculture
  • 8.3. Cosmetics & Personal Care
  • 8.4. Drug Development & Delivery
  • 8.5. Food Industry

9. Americas Glycolipids Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Glycolipids Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Glycolipids Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

  • 13.1. Key Company Profiles
    • 13.1.1. AkzoNobel N.V.
    • 13.1.2. BASF SE
    • 13.1.3. Biosynth Ltd.
    • 13.1.4. Cargill Incorporated
    • 13.1.5. CD Bioparticles
    • 13.1.6. Croda International PLC
    • 13.1.7. DuPont de Nemours, Inc.
    • 13.1.8. Ecover
    • 13.1.9. Evonik Industries AG
    • 13.1.10. Givaudan SA
    • 13.1.11. Henkel Corporation
    • 13.1.12. Jeneil Biotech, Inc.
    • 13.1.13. Koninklijke DSM N.V.
    • 13.1.14. LANXESS Deutschland GmbH
    • 13.1.15. Lasenor Emul S.A.
    • 13.1.16. Lecico GmbH
    • 13.1.17. Lipoid GmbH
    • 13.1.18. Locus Performance Ingredients
    • 13.1.19. Lyxia Corporation
    • 13.1.20. Patanjali Foods Ltd.
    • 13.1.21. Qualitas Health
    • 13.1.22. Solvay S.A.
    • 13.1.23. Stern-Wywiol Gruppe GmbH & Co. KG
    • 13.1.24. The Archer-Daniels-Midland Company
    • 13.1.25. The Lubrizol Corporation
    • 13.1.26. Vav Life Sciences
  • 13.2. Key Product Portfolio

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing